he Ontario COVID-19 Science Advisory Table is a group of scientific experts and health system leaders who evaluate and report on emerging evidence relevant to the COVID-19 pandemic, to inform Ontario’s response.
Published: April 26, 2021
Source: https://covid19-sciencetable.ca/
Presenters: Laveena Munshi MD MSc, Stephanie Carlin PharmD, Beth Leung PharmD MsCI
Moderator: Brad Langford PharmD
Objectives:
- Summarize the data on the use of tocilizumab in patients with COVID-19
- Describe the recommended populations to receive tocilizumab
- Provide advice and considerations regarding secondary infections
- Discuss access and use of tocilizumab in the context of a shortage situation
Watch the full webinar here.